Following the announcement 8 May 2019 of the appointment of Jon Stanton to the Board of Directors of Imperial Brands PLC (the Company) with effect from 8 May 2019, the information below is given in compliance with rule 9.6.13 of the Financial Conduct Authority Listing Rules Sourcebook.
Jonathan Stanton
|
1 |
Holds the current directorships in publicly quoted companies over the five years preceding the date of his appointment.
The Weir Group PLC
|
|
2 |
Does not have any unspent convictions in relation to indictable offences.
|
|
3 |
Has not been an executive director of a company at the time of or within the 12 months preceding any receivership, compulsory liquidation, creditors voluntary liquidation, administration, company voluntary arrangements or any composition or arrangement with its creditors generally or any class of its creditors.
|
|
4 |
Has not been a partner in a partnership at the time or within 12 months preceding any compulsory liquidation, administration or partnership voluntary arrangement of that partnership.
|
|
5 |
Has not had any assets which have been subject to receivership and has not been a partner in a partnership at the time of such receivership or within the 12 months preceding such receivership.
|
|
6 |
Has not been publicly criticised by any statutory or regulatory authority (including any designated professional body) and has not been disqualified by a court from acting as a director of a company or from acting in the management or conduct of the affairs of any company.
|
The Company was advised that upon the appointment becoming effective Jonathan Stanton did not have any ordinary shares of 10p each in the Company.
T M Williams
Deputy Company Secretary
Copies of our announcements are available on our website: www.imperialbrandsplc.com/Investors/Stock-Exchange-announcements
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
